• Mashup Score: 0

    AstraZeneca’s new drug, a monoclonal antibody, was given FDA approval after the Antimicrobial Drugs Advisory Committee (AMDAC) to the FDA voted in June to recommend the approval of nirsevimab (Beyfortus) for the prevention of respiratory syncytial virus (RSV) disease in infants.

    Tweet Tweets with this article
    • AstraZeneca's new drug, a monoclonal antibody, was given FDA approval after the Antimicrobial Drugs Advisory Committee (AMDAC) to the FDA voted in June to recommend the approval of nirsevimab (Beyfortus). https://t.co/aTUgS97M8F #RSV #astrazeneca

  • Mashup Score: 0

    January 9, 2023 — CinCor Pharma, Inc. announced that it has entered into a definitive agreement with AstraZeneca under which AstraZeneca has agreed to acquire CinCor. Marc de Garidel, Chief Executive Officer at CinCor, said: “We are excited about the proposed acquisition of CinCor Pharma by AstraZeneca as we believe it offers the prospect of accelerating the development timeline and expanding the…

    Tweet Tweets with this article
    • @DAICeditor @cincorpharma @AstraZenecaUS #CinCor Pharma, Inc. announced that it has entered into a definitive agreement with #AstraZeneca under which AstraZeneca has agreed to #acquire CinCor: https://t.co/lYe55UAdfT

  • Mashup Score: 4

    A database analysis showed no association between messenger RNA COVID-19 vaccines and risk for acute MI, stroke or pulmonary embolism, but a slight increase in risk for PE and MI after receiving the AstraZeneca or Janssen vaccines.“In a previous study, we found no increase in the rate of acute MI, stroke or PE after each dose of the Pfizer-BioNTech vaccine in persons aged 75 years or older

    Tweet Tweets with this article
    • Researchers found no association between #messengerRNA #COVID19 #vaccines and risk for acute MI, stroke or PE, but a slight increase in risk after receiving the #AstraZeneca or #Janssen vaccines @JeremieBotton @AnnalsofIM @HealioPulm #CardioTwitter https://t.co/k6GhzsRCvR